HuGE Literature Finder
Records
1
-
10
| TET2, ASXL1, IDH1, and IDH2 Single Nucleotide Polymorphisms in Turkish Patients with Chronic Myeloproliferative Neoplasms. Turkish journal of haematology : official journal of Turkish Society of Haematology 2017 Feb . Soyer Nur, Tezcanl? Kaymaz Burçin, Cömert Özkan Melda, Aktan Ça?da?, Küçükaslan Ali ?ahin, ?ahin Fahri, Kosova Buket, Saydam Gür |
| Application of an NGS-based 28-gene panel in myeloproliferative neoplasms reveals distinct mutation patterns in essential thrombocythaemia, primary myelofibrosis and polycythaemia vera. British journal of haematology 2016 Nov 175 (3): 419-426. Delic Sabit, Rose Dominic, Kern Wolfgang, Nadarajah Niroshan, Haferlach Claudia, Haferlach Torsten, Meggendorfer Man |
| The Clinical Significance of IDH Mutations in Essential Thrombocythemia and Primary Myelofibrosis. Journal of clinical medicine research 2016 Jan 8 (1): 29-39. Yonal-Hindilerden Ipek, Daglar-Aday Aynur, Hindilerden Fehmi, Akadam-Teker Basak, Yilmaz Ceylan, Nalcaci Meliha, Yavuz Akif Selim, Sargin Den |
| A compendium of cytogenetic abnormalities in myelofibrosis: molecular and phenotypic correlates in 826 patients. British journal of haematology 2015 Apr 169 (1): 71-6. Wassie Emnet, Finke Christy, Gangat Naseema, Lasho Terra L, Pardanani Animesh, Hanson Curtis A, Ketterling Rhett P, Tefferi Ayal |
| CALR mutation screening in pediatric primary myelofibrosis. Pediatric blood & cancer 2014 Dec 61 (12): 2256-62. An Wenbin, Wan Yang, Guo Ye, Chen Xiaojuan, Ren Yuanyuan, Zhang Jingliao, Chang Lixian, Wei Wei, Zhang Peihong, Zhu Xiaof |
| Mutations and prognosis in primary myelofibrosis. Leukemia 2013 Sep 27 (9): 1861-9. Vannucchi A M, Lasho T L, Guglielmelli P, Biamonte F, Pardanani A, Pereira A, Finke C, Score J, Gangat N, Mannarelli C, Ketterling R P, Rotunno G, Knudson R A, Susini M C, Laborde R R, Spolverini A, Pancrazzi A, Pieri L, Manfredini R, Tagliafico E, Zini R, Jones A, Zoi K, Reiter A, Duncombe A, Pietra D, Rumi E, Cervantes F, Barosi G, Cazzola M, Cross N C P, Tefferi |
| TET2, ASXL1, IDH1, IDH2, and c-CBL genes in JAK2- and MPL-negative myeloproliferative neoplasms. Annals of hematology 2012 Apr 91 (4): 533-41. Martínez-Avilés Luz, Besses Carlos, Álvarez-Larrán Alberto, Torres Erica, Serrano Sergi, Bellosillo Beatr |
| IDH mutations in primary myelofibrosis predict leukemic transformation and shortened survival: clinical evidence for leukemogenic collaboration with JAK2V617F. Leukemia 2012 Mar 26 (3): 475-80. Tefferi A, Jimma T, Sulai N H, Lasho T L, Finke C M, Knudson R A, McClure R F, Pardanani |
| IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis. Leukemia 2010 Jul 24 (7): 1302-9. Tefferi A, Lasho T L, Abdel-Wahab O, Guglielmelli P, Patel J, Caramazza D, Pieri L, Finke C M, Kilpivaara O, Wadleigh M, Mai M, McClure R F, Gilliland D G, Levine R L, Pardanani A, Vannucchi A |
| IDH1 and IDH2 mutation analysis in chronic- and blast-phase myeloproliferative neoplasms. Leukemia 2010 Jun 24 (6): 1146-51. Pardanani A, Lasho T L, Finke C M, Mai M, McClure R F, Tefferi |
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 16, 2022
- Content source: